Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Hepatol. 2016 Nov 2;66(3):545–551. doi: 10.1016/j.jhep.2016.10.029

Fig. 1. Efficacy data for study population.

Fig. 1

(A) Swimmer’s plot showing time on study, off-treatment reason, current status and time of response if applicable; the arrow indicates patients still on study; white circle, time of response; blue circle, time of discontinuation due to toxicity. (B) Plot showing magnitude of change in target lesion sum over time as per RECIST; patients evaluable in target lesions not treated by RFA/TACE.

HHS Vulnerability Disclosure